https://pmc.ncbi.nlm.nih.gov/articles/PMC10570688/
Effect of tauroursodeoxycholic acid on survival and safety in amyotrophic lateral sclerosis: a...
Oral tauroursodeoxycholic acid (TUDCA) is a commercial drug currently tested in patients with amyotrophic lateral sclerosis (ALS) both singly and combined with...
survival and safety